During the past decade, Chicago Research Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 14 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chicago Research Center" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Glaxo Wellcome" with 3 trials sponsored, "Merck Sharp & Dohme LLC" with 3 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 3 trials sponsored and "Antiva Biosciences" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chicago Research Center" #1 collaborator was "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chicago Research Center" are "HIV Infections" (12 trials), "Major Depressive Disorder" (8 trials), "Depressive Disorder, Major" (5 trials), "Alzheimer Disease" (3 trials) and "Fibromyalgia" (3 trials). Many other conditions were trialed in "Chicago Research Center" in a lesser frequency.

Most popular intervention types in "Chicago Research Center" are "Drug" (48 trials), "Device" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Lamivudine" (5 trials), "Indinavir sulfate" (4 trials), "Zidovudine" (4 trials) and "Stavudine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Chicago Research Center" are 51 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Chicago Research Center". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Chicago Research Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Chicago Research Center, 4 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".